Shorter radiation plan for certain early cervical cancers
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a feasibility (“can it be done safely?”) approach that delivers radiation in a shorter schedule for some cervical cancer patients. It also uses weekly cisplatin chemotherapy and includes a radiation procedure called brachytherapy to improve treatment effectiveness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your cervical cancer stage fits specific groups (roughly IB2 to IIB, or certain IIIC1 cases)
- Your cancer type is invasive squamous, adenocarcinoma, or adenosquamous
- You are able to have both the planned chemo (weekly cisplatin) and brachytherapy
- You can safely have an MRI scan, and your overall health is not very limited (ECOG 0–3)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter, personalized radiation schedule for cervical cancer. It uses daily CT scans to adjust the radiation beam for better targeting. It may mean fewer hospital visits and less damage to healthy tissue.
This trial tests a shorter course of high-precision radiation therapy given at the same time as chemotherapy for cervical cancer that has not spread to distant organs. It aims to find if this approach is effective and safe for patients with locally advanced disease.
This trial tests a shorter, more targeted type of radiation therapy for people with endometrial or cervical cancer who have had surgery. It aims to reduce side effects by using daily scans to adjust the treatment plan.
This trial studies a shorter, focused radiation schedule given after surgery for certain higher-risk cervical or endometrial (uterine) cancers. It may help reduce cancer recurrence while checking side effects in the bladder and bowel area.
This Phase 1 study tests whether KRC-01, given by injection into the tumor, is safe and tolerable when combined with standard chemoradiation for locally advanced cervical cancer. It also looks for early signs that the treatment can shrink tumors.
This trial tests a type of radiation that adapts to your body changes during treatment for cervical cancer. It aims to improve accuracy and reduce side effects.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.